본문 바로가기
HOME> 논문 > 논문 검색상세

논문 상세정보

Diabetic medicine : a journal of the British Diabetic Association v.34 no.3, 2017년, pp.372 - 379   SCI SCIE
본 등재정보는 저널의 등재정보를 참고하여 보여주는 베타서비스로 정확한 논문의 등재여부는 등재기관에 확인하시기 바랍니다.

Association between serum 25(OH)D3 and cardiovascular morbidity and mortality in people with Type 2 diabetes: a community‐based cohort study

Samefors, M. (Department of Medical and Health Sciences, Linköping University, Linköping, Sweden ) ; Scragg, R. (School of Population Health, University of Auckland, Auckland, New Zealand ) ; Länne, T. (Department of Medical and Health Sciences, Linköping University, Linköping, Sweden ) ; Nyström, F. H. (Department of Medical and Health Sciences, Linköping University, Linköping, Sweden ) ; Östgren, C. J. (Department of Medical and Health Sciences, Linköping University, Linköping, Sweden ) ;
  • 초록  

    Abstract Aim We aimed to explore the association between vitamin D and cardiovascular morbidity and mortality in people with Type 2 diabetes recruited from a community‐based study because there is limited and inconsistent research of this group. Methods A prospective community‐based cohort study among people aged 55–66 years with Type 2 diabetes as part of The Cardiovascular Risk in Type 2 Diabetes – A Prospective Study in Primary Care (CARDIPP). We analysed serum 25‐hydroxyvitamin D 3 [25(OH)D 3 ] at baseline. Cox regression analyses were used to calculate hazard ratios (HR) for the first myocardial infarction, stroke or cardiovascular mortality according to 25(OH)D 3 . Results We examined 698 people with a mean follow‐up of 7.3 years. Serum 25(OH)D 3 was inversely associated with the risk of cardiovascular morbidity and mortality: HR 0.98 [95% confidence interval (CI) 0.96 to 0.99, P = 0.001]. Compared with the fourth quartile (Q4) [25(OH)D 3 > 61.8 nmol/l], HR (with 95% CI) was 3.46 (1.60 to 7.47) in Q1 [25(OH)D 3 P = 0.002); 2.26 (1.01 to 5.06) in Q2 [25(OH)D 3 35.5–47.5 nmol/l] ( P = 0.047); and 1.62 (0.70 to 3.76) in Q3 [25(OH)D 3 47.5–61.8 nmol/l] ( P = 0.26) when adjusting for age, sex and season. The results remained significant after adjusting also for cardiovascular risk factors, physiological variables including parathyroid hormone and previous cardiovascular disease ( P = 0.027). Conclusions Low 25(OH)D 3 is associated with an increased risk of cardiovascular morbidity and mortality in people with Type 2 diabetes independent of parathyroid hormone. Vitamin D could be considered as a prognostic factor. Future studies are needed to explore whether vitamin D deficiency is a modifiable risk factor in Type 2 diabetes.


    What's new? There is limited research on vitamin D and cardiovascular disease in people with Type 2 diabetes.We found that serum 25‐hydroxyvitamin D 3 was inversely associated with the risk of cardiovascular morbidity and mortality in people with Type 2 diabetes.The results remained significant after adjusting for cardiovascular risk factors, physiological variables and previous cardiovascular disease.The results of our study expand the current knowledge of the importance of vitamin D in relation to cardiovascular disease because we incorporated data on parathyroid hormone levels and physical activity in the analyses.Vitamin D could be considered as a prognostic factor.


 활용도 분석

  • 상세보기

    amChart 영역
  • 원문보기

    amChart 영역

원문보기

무료다운로드
  • 원문이 없습니다.
유료다운로드

유료 다운로드의 경우 해당 사이트의 정책에 따라 신규 회원가입, 로그인, 유료 구매 등이 필요할 수 있습니다. 해당 사이트에서 발생하는 귀하의 모든 정보활동은 NDSL의 서비스 정책과 무관합니다.

원문복사신청을 하시면, 일부 해외 인쇄학술지의 경우 외국학술지지원센터(FRIC)에서
무료 원문복사 서비스를 제공합니다.

NDSL에서는 해당 원문을 복사서비스하고 있습니다. 위의 원문복사신청 또는 장바구니 담기를 통하여 원문복사서비스 이용이 가능합니다.

이 논문과 함께 출판된 논문 + 더보기